(1R,2R,4S,5S)-tricyclo[3.1.0.0~2,4~]hexane
CAS No. 21531-33-9
(1R,2R,4S,5S)-Tricyclo[3.1.0.0~2,4~]hexane; tricyclo[3.1.0.0~2,4~]hexane, (1R,2R,4S,5S)-
propan-2-yl diprop-2-en-1-ylcarbamate
25070-72-8
cyacrin
25067-30-5
2-(1H-imidazol-1-yl)isonicotinonitrile
158020-84-9
Mg.O.Pb.Ti.W
158033-02-4
Propanenitrile,2-hydroxy-3-phenoxy-, (2S)-
250670-80-5
Doptcga
158010-68-5
2-Propenoic acid, polymer with 1,3-butadiene
25067-26-9
FA-ARG-LEU-OH
158016-08-1
2-Propenal, 3-[4-(diphenylamino)phenyl]-
25069-77-6
Benzonitrile, 4-(2-nitro-1-propenyl)-
15804-74-7
1,2-dehydro-N-beta-alanyldopamine
158018-58-7
1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-4-PIPERIDONE
250718-99-1
Benzenepropanoic acid, 4-(diphenylamino)-
25069-75-4
ENV antigen(hepatitis C virus patient #4)
158028-13-8
1-CBZ-吡咯烷
Manganese, pentacarbonylgermyl-
25069-08-3
Carbamic acid, methyl-, 2-propenyl ester
25070-81-9
Phenol, 4-(diphenylamino)-
25069-86-7
Cyclohexanone, 3-(2-naphthalenyl)-, (3S)-
250782-41-3
3-Chlorophenylcarbamic acid allyl ester
25070-79-5
18-deoxyaldosterone
2507-88-2
(E)-3-oxiranylacrylaldehyde
25073-24-9
1-O-(5-carboxypentyl)glycero-3-phosphothreonine
158059-97-3
CrH2O4·xPb
15804-54-3
CH2N2O3S
15804-29-2
FTASE INHIBITOR III
158022-12-9
2H-Pyran, 2-cyclohexyl-5,6-dihydro-
158070-12-3
Phenol,4-[2-(1-methylethylidene)cyclopropyl]-
250750-46-0
4-[benzyl(methyl)amino]benzoic acid
25070-91-1
3-[4-(Diphenylamino)phenyl]propenoic acid
25069-29-8
Cyclohexanemethanol, 4-(2-propynyl)-, trans-
250682-79-2
2-Oxazolidinone,3-(1,2-propadien-1-yl)-
250728-91-7
Ethanone,1-(3,5-dimethyl-1-piperazinyl)-
250739-61-8